Integra LifeSciences Holdings Corp. (IART)
13.44
+0.03
(+0.22%)
USD |
NASDAQ |
Oct 09, 16:00
13.44
0.00 (0.00%)
After-Hours: 20:00
Integra LifeSciences Holdings Free Cash Flow : 11.60M for June 30, 2026
Free Cash Flow Chart
Historical Free Cash Flow Data
| Date | Value |
|---|---|
| June 30, 2026 | 11.60M |
| March 31, 2026 | -10.12M |
| December 31, 2025 | -45.25M |
| September 30, 2025 | -14.47M |
| June 30, 2025 | -47.38M |
| March 31, 2025 | -25.46M |
| December 31, 2024 | 15.01M |
| September 30, 2024 | 38.04M |
| June 30, 2024 | 58.89M |
| March 31, 2024 | 60.93M |
| December 31, 2023 | 73.09M |
| September 30, 2023 | 109.75M |
| June 30, 2023 | 155.22M |
| March 31, 2023 | 199.56M |
| December 31, 2022 | 217.38M |
| September 30, 2022 | 188.30M |
| June 30, 2022 | 204.63M |
| March 31, 2022 | 232.22M |
| December 31, 2021 | 264.35M |
| September 30, 2021 | 274.39M |
| June 30, 2021 | 261.81M |
| March 31, 2021 | 203.05M |
| December 31, 2020 | 139.94M |
| September 30, 2020 | 155.10M |
| June 30, 2020 | 77.84M |
| Date | Value |
|---|---|
| March 31, 2020 | 82.80M |
| December 31, 2019 | 96.90M |
| September 30, 2019 | 41.88M |
| June 30, 2019 | 118.81M |
| March 31, 2019 | 104.16M |
| December 31, 2018 | 116.90M |
| September 30, 2018 | 102.79M |
| June 30, 2018 | 77.66M |
| March 31, 2018 | 77.49M |
| December 31, 2017 | 71.04M |
| September 30, 2017 | 58.53M |
| June 30, 2017 | 60.87M |
| March 31, 2017 | 99.66M |
| December 31, 2016 | 79.97M |
| September 30, 2016 | 117.30M |
| June 30, 2016 | 98.55M |
| March 31, 2016 | 48.72M |
| December 31, 2015 | 71.44M |
| September 30, 2015 | 57.08M |
| June 30, 2015 | 58.33M |
| March 31, 2015 | 60.34M |
| December 31, 2014 | 37.54M |
| September 30, 2014 | 30.81M |
| June 30, 2014 | 26.07M |
| March 31, 2014 | 8.343M |
Free Cash Flow Range, Past 5 Years
--
Minimum
--
Maximum
--
Average
--
Median
Free Cash Flow Benchmarks
| Penumbra, Inc. | 215.91M |
| Boston Scientific Corp. | 3.625B |
| Globus Medical, Inc. | 750.84M |
| Sight Sciences, Inc. | -23.33M |
| Abbott Laboratories | 7.824B |
Free Cash Flow Related Metrics
| Cash from Operations (Quarterly) | 22.80M |
| Cash from Investing (Quarterly) | -43.28M |
| Cash from Financing (Quarterly) | -0.818M |
| Free Cash Flow Per Share (Quarterly) | 0.1343 |
| Free Cash Flow to Equity (Quarterly) | 1.069M |
| Free Cash Flow to Firm (Quarterly) | 36.32M |
| Free Cash Flow Yield | 1.11% |